Who invested in HanBio Therapeutics?
HanBio Therapeutics's investors include OrbiMed and Yonghua Capital.
Who invested in HanBio Therapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $40MJan 2022
- Investors
- 2
The rounds
- Jan 2022
Everyone who backed them
Yonghua CapitalVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about HanBio Therapeutics
How much has HanBio Therapeutics raised?
HanBio Therapeutics has raised $40M across 1 round since 2022.
When did HanBio Therapeutics last raise?
HanBio Therapeutics's most recent round was a Series A of $40M in Jan 2022.
What was HanBio Therapeutics's biggest round?
Its most recent round, $40M in Jan 2022, is also its largest on record.
Who backed HanBio Therapeutics first?
HanBio Therapeutics's first round on record, in Jan 2022, was backed by OrbiMed and Yonghua Capital.
What stage is HanBio Therapeutics at?
HanBio Therapeutics's latest named round is a Series A, in Jan 2022.
Companies like HanBio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.